Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against

Staphylococcus aureus antimicrobial peptides bacterial biofilms bioimaging techniques combination therapy

Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
13 10 2023
Historique:
medline: 23 10 2023
pubmed: 5 9 2023
entrez: 5 9 2023
Statut: ppublish

Résumé

The formation of biofilms is a common virulence factor that makes bacterial infections difficult to treat and a major human health problem. Biofilms are bacterial communities embedded in a self-produced matrix of extracellular polymeric substances (EPS). In this work, we show that vCPP2319, a polycationic peptide derived from the capsid protein of Torque teno douroucouli virus, is active against preformed

Identifiants

pubmed: 37669146
doi: 10.1021/acsinfecdis.3c00195
pmc: PMC10580319
doi:

Substances chimiques

Antimicrobial Peptides 0
alpha-Amylases EC 3.2.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1889-1900

Références

Nat Nanotechnol. 2017 Apr 6;12(4):295-307
pubmed: 28383040
ACS Omega. 2017 Sep 30;2(9):5861-5872
pubmed: 30023754
Curr Opin Pharmacol. 2013 Oct;13(5):699-706
pubmed: 23871261
J Pept Sci. 2015 Jul;21(7):530-9
pubmed: 26100854
Biochem Pharmacol. 2017 Jun 1;133:117-138
pubmed: 27663838
Appl Environ Microbiol. 2007 May;73(10):3283-90
pubmed: 17384309
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
Biochim Biophys Acta. 2012 Dec;1818(12):3141-8
pubmed: 22897980
BMC Microbiol. 2015 Feb 18;15:36
pubmed: 25881030
Biofouling. 2014;30(4):435-46
pubmed: 24645694
Biochim Biophys Acta. 2016 May;1858(5):1044-60
pubmed: 26525663
Diabet Foot Ankle. 2012;3:
pubmed: 22577496
Trends Biotechnol. 2011 Sep;29(9):464-72
pubmed: 21680034
ACS Infect Dis. 2018 Feb 9;4(2):93-106
pubmed: 29280609
J Microbiol Methods. 2008 Feb;72(2):157-65
pubmed: 18155789
Curr Pharm Des. 2015;21(1):67-84
pubmed: 25189860
Diabetes Res Clin Pract. 2012 Jan;95(1):153-61
pubmed: 22019426
J Antimicrob Chemother. 2019 Sep 1;74(9):2617-2625
pubmed: 31127270
Peptides. 2011 Sep;32(9):1807-14
pubmed: 21849157
Clin Microbiol Rev. 2006 Jul;19(3):491-511
pubmed: 16847082
J Biomed Sci. 2016 Mar 08;23:33
pubmed: 26952716
Nat Rev Microbiol. 2017 Dec;15(12):740-755
pubmed: 28944770
Expert Rev Anti Infect Ther. 2018 Jan;16(1):51-65
pubmed: 29235402
Pharmaceutics. 2019 Apr 04;11(4):
pubmed: 30987353
J Ind Microbiol Biotechnol. 2007 Jan;34(1):1-4
pubmed: 16463160
Virulence. 2011 Sep-Oct;2(5):445-59
pubmed: 21921685
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Rev Microbiol. 2004 Feb;2(2):95-108
pubmed: 15040259
Adv Colloid Interface Sci. 2017 Sep;247:573-588
pubmed: 28754382
Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:46-53
pubmed: 22271723
Clin Transl Sci. 2021 Jul;14(4):1349-1358
pubmed: 33641212
J Lab Autom. 2014 Dec;19(6):555-61
pubmed: 25124156
Microb Drug Resist. 2017 Apr;23(3):384-390
pubmed: 27754780
J Biol Chem. 2018 Feb 2;293(5):1536-1549
pubmed: 29255091
J Innate Immun. 2013;5(1):24-38
pubmed: 22922323
Front Microbiol. 2017 May 04;8:775
pubmed: 28522994
Front Microbiol. 2017 Dec 07;8:2409
pubmed: 29375486
J Biol Chem. 2010 Sep 3;285(36):27536-44
pubmed: 20566635
PLoS One. 2012;7(7):e41747
pubmed: 22848588
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
Nat Rev Microbiol. 2016 Aug 11;14(9):563-75
pubmed: 27510863
Eur J Biochem. 2000 Sep;267(17):5421-6
pubmed: 10951200
Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a000398
pubmed: 20519345
Biochim Biophys Acta. 1999 Dec 15;1462(1-2):11-28
pubmed: 10590300
J Pept Sci. 2019 Aug;25(8):e3195
pubmed: 31317613
Antimicrob Resist Infect Control. 2019 May 16;8:76
pubmed: 31131107
BMC Med. 2015 Jan 07;13:2
pubmed: 25564342
Nat Rev Drug Discov. 2003 Feb;2(2):114-22
pubmed: 12563302
Bioinformatics. 2015 Jul 15;31(14):2252-6
pubmed: 25725499
Biomolecules. 2018 Jan 19;8(1):
pubmed: 29351202
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
FEBS J. 2017 Nov;284(21):3662-3683
pubmed: 28892294

Auteurs

Susana A Dias (SA)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Sandra N Pinto (SN)

iBB-Institute for Bioengineering and Biosciences and Associate Laboratory i4HB - Institute for Health and Bioeconomy at Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.

Ana S Silva-Herdade (AS)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Marco Cavaco (M)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Vera Neves (V)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Luís Tavares (L)

CIISA - Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, Av. da Universidade Técnica, 1300-477 Lisboa, Portugal.
Laboratório Associado para Ciência Animal e Veterinária (AL4AnimalS), 1300-477 Lisboa, Portugal.

Manuela Oliveira (M)

CIISA - Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, Av. da Universidade Técnica, 1300-477 Lisboa, Portugal.
Laboratório Associado para Ciência Animal e Veterinária (AL4AnimalS), 1300-477 Lisboa, Portugal.

David Andreu (D)

Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003 Barcelona, Spain.

Ana Coutinho (A)

iBB-Institute for Bioengineering and Biosciences and Associate Laboratory i4HB - Institute for Health and Bioeconomy at Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

Miguel A R B Castanho (MARB)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Ana Salomé Veiga (AS)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH